Another oral medication for people with type 1 diabetes recently struck out with the FDA, but approvals in Europe and Japan lead us to believe that the game isn’t yet over here in the states.
read more →
A new oral medication for T1D is awaiting FDA approval, and it’s shown fewer highs, fewer lows, and more predictable insulin dosing in recent studies.
read more →